GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma Meeting Abstract
| Authors: | Wen, P. Y.; Mellinghoff, I. K.; Buxton, M. B.; Cavenee, W. K.; Colman, H.; De Groot, J. F.; Ellingson, B. M.; Gordon, G. B.; Khasraw, M.; Lassman, A. B.; Lim, M.; Perry, J. R.; Tanner, K.; Weller, M.; Yung, W. K. A. A.; Cloughesy, T. F.; GBM AGILE Investigators |
| Abstract Title: | GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120306194 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS2074 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS2074 -- Source: Wos |
